HEM Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	337,281	327,494	114,874
Market Cap Growth	122.74%	185.09%	-
Enterprise Value	344,529	334,986	-
Last Close Price	47000.00	45850.00	16500.00
PS Ratio	23.40	25.23	7.62
PB Ratio	194.61	62.80	4.40
P/TBV Ratio	-	92.81	4.54
EV/Sales Ratio	23.91	25.81	-
Debt / Equity Ratio	11.21	3.69	0.30
Net Debt / Equity Ratio	4.02	1.05	-0.13
Net Debt / EBITDA Ratio	-0.48	-0.42	0.66
Net Debt / FCF Ratio	-0.39	-0.30	0.28
Asset Turnover	0.32	0.29	-
Inventory Turnover	12.82	9.97	-
Quick Ratio	0.34	0.38	1.73
Current Ratio	0.48	0.56	1.91
Return on Equity (ROE)	-194.38%	-151.43%	-
Return on Assets (ROA)	-23.77%	-21.96%	-
Return on Capital Employed (ROCE)	-218.20%	-137.30%	-27.60%
Earnings Yield	-7.59%	-7.28%	-6.66%
FCF Yield	-5.27%	-5.53%	-10.77%
Buyback Yield / Dilution	-8.77%	-10.68%	-